Editing Nuance Communications, Inc.
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 63: | Line 63: | ||
The AI in healthcare market is filled with promising prospects. Companies are utilising a range of technological advancements to enhance patient outcomes and decrease treatment expenses. The increasing elderly population worldwide, lifestyle changes, and higher incidence of chronic illnesses have led to a significant rise in the need for early disease diagnosis and better disease comprehension. To meet these demands, healthcare systems are extensively adopting and incorporating Artificial Intelligence (AI) and machine learning (ML) algorithms. Some key players in this field who are competitors for Nuance and now Microsoft too after the acquisition are: | The AI in healthcare market is filled with promising prospects. Companies are utilising a range of technological advancements to enhance patient outcomes and decrease treatment expenses. The increasing elderly population worldwide, lifestyle changes, and higher incidence of chronic illnesses have led to a significant rise in the need for early disease diagnosis and better disease comprehension. To meet these demands, healthcare systems are extensively adopting and incorporating Artificial Intelligence (AI) and machine learning (ML) algorithms. Some key players in this field who are competitors for Nuance and now Microsoft too after the acquisition are: | ||
* IBM Corporation - In April 2023, IBM Corporation partnered with Moderna Inc. to integrate AI and quantum computing into mRNA development. The collaboration involves investments in generative AI to enhance product design, | * IBM Corporation - In April 2023, IBM Corporation partnered with Moderna Inc. to integrate AI and quantum computing into mRNA development. The collaboration involves investments in generative AI to enhance product design, utilizing the MoLFormer AI model to optimize mRNA and lipid nanoparticles. | ||
* NVIDIA Corporation - In March 2023, NVIDIA Corporation and Medtronic Plc. joined forces with Cosmo Pharmaceuticals to advance AI capabilities in colonoscopy procedures. Medtronic plans to integrate NVIDIA's AI technology into its GI Genius Intelligent Endoscopy Module, creating the GI Genius AI Access platform for healthcare AI innovation. | * NVIDIA Corporation - In March 2023, NVIDIA Corporation and Medtronic Plc. joined forces with Cosmo Pharmaceuticals to advance AI capabilities in colonoscopy procedures. Medtronic plans to integrate NVIDIA's AI technology into its GI Genius Intelligent Endoscopy Module, creating the GI Genius AI Access platform for healthcare AI innovation. | ||
* Intel Corporation | * Intel Corporation |